Publication Name	World Journal of Diabetes
Manuscript ID	7748
Country	Saudi Arabia

Received	2013-11-30 12:37
Peer-Review Started	2013-11-30 13:59
To Make the First Decision	2014-02-27 10:07
Return for Revision	2014-03-04 20:45
Revised	2014-06-16 00:00
Second Decision	2014-07-15 14:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-07-15 15:03
Articles in Press	2014-07-15 17:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-08-05 18:40
Publish the Manuscript Online	2014-08-17 13:16

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Prospective Study
Article Title	Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment
Manuscript Source	Invited Manuscript
All Author List	J Fernando Arevalo, Martin A Serrano and Juan D Arias
Funding Agency and Grant Number	Funding Agency Grant Number Arevalo-Coutinho Foundation for Research in Ophthalmology, Caracas, Venezuela
Corresponding Author	J Fernando Arevalo, MD, FACS, Chief of the Vitreoretinal Division, King Khaled Eye Specialist Hospital, Al-Oruba Street, PO Box 7191, Riyadh 11462, Saudi Arabia. arevalojf@jhmi.edu
Key Words	Avastin; Intravitreal bevacizumab; Intravitreal injections; Proliferative diabetic retinopathy; Tractional retinal detachment; Perfluorodissection; Minimally invasive vitreoretinal surgery; Vitrectomy
Core Tip	En bloc perfluorodissection and preoperative intravitreal bevacizumab use for small-gauge vitrectomy in patients with proliferative diabetic retinopathy and tractional retinal detachment are very useful, the combination reduces complications and operative time. En bloc perfluorodissection and preoperative intravitreal bevacizumab use seems to have many advantages including that the retina remains stable during vitrectomy, better visibility of the ocular structures in the vitreous cavity, immediate reattachment of the retina, bleeding control, subretinal fluid reabsorbsion and drainage, bleeding sites’ tamponade, and easier dissection of epiretinal tissues.
Publish Date	2014-08-17 13:16
Citation	Arevalo JF, Serrano MA, Arias JD. Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment. World J Diabetes 2014; 5(5): 724-729
URL	http://www.wjgnet.com/1948-9358/full/v5/i5/724.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i5.724

Full Article (PDF)	WJD-5-724.pdf
Full Article (Word)	WJD-5-724.doc
Manuscript File	7748-Review.doc
Answering Reviewers	7748-Answering reviewers.pdf
Copyright License Agreement	7748-Copyright assignment.pdf
Peer-review Report	7748-Peer review(s).pdf
Scientific Misconduct Check	7748-CrossCheck.jpg
Scientific Editor Work List	7748-Scientific editor work list.pdf